The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Beraprost Sodium Market Research Report 2025
Synopsis
Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects.
The global Beraprost Sodium market was valued at US$ 116.6 million in 2023 and is anticipated to reach US$ 133.6 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
The Beraprost Sodium market is driven by the rising prevalence of peripheral arterial disease (PAD) and the growing demand for effective treatment options. Beraprost Sodium is a prostacyclin analog used to improve blood flow and manage symptoms in patients with PAD, a condition characterized by reduced blood flow to the extremities. The increase in risk factors such as diabetes, smoking, and obesity contributes to market growth. The development of oral formulations of Beraprost Sodium has improved patient convenience and adherence to treatment. However, the market also faces challenges, including the need for long-term treatment and the potential for side effects in some patients. Additionally, cost considerations and reimbursement issues can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and cost-effective Beraprost Sodium formulations, collaborate with healthcare providers to improve disease management, and address the challenges to meet the increasing demand for effective PAD treatment options.
This report aims to provide a comprehensive presentation of the global market for Beraprost Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beraprost Sodium.
Report Scope
The Beraprost Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Beraprost Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beraprost Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Toray
Taide Pharma
Nichiiko
Daiichi Sankyo Co Ltd
Nihon Generic Co Ltd
Yoshindo
NABIQASIM INDUSTRIES
Shin Poong Pharmaceutical
Ohara Inc
Kyorin Holding
KYOUSOUMIRAI PHARM
Teva
Alfresa Pharma
Lupin Laboratories
Astellas Pharma
Sawai Pharmaceutical
Viatris
Kaken Pharmaceutical
Segment by Type
Tablet
Sustained Release Tablets
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Beraprost Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects.
The global Beraprost Sodium market was valued at US$ 116.6 million in 2023 and is anticipated to reach US$ 133.6 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
The Beraprost Sodium market is driven by the rising prevalence of peripheral arterial disease (PAD) and the growing demand for effective treatment options. Beraprost Sodium is a prostacyclin analog used to improve blood flow and manage symptoms in patients with PAD, a condition characterized by reduced blood flow to the extremities. The increase in risk factors such as diabetes, smoking, and obesity contributes to market growth. The development of oral formulations of Beraprost Sodium has improved patient convenience and adherence to treatment. However, the market also faces challenges, including the need for long-term treatment and the potential for side effects in some patients. Additionally, cost considerations and reimbursement issues can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and cost-effective Beraprost Sodium formulations, collaborate with healthcare providers to improve disease management, and address the challenges to meet the increasing demand for effective PAD treatment options.
This report aims to provide a comprehensive presentation of the global market for Beraprost Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beraprost Sodium.
Report Scope
The Beraprost Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Beraprost Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beraprost Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Toray
Taide Pharma
Nichiiko
Daiichi Sankyo Co Ltd
Nihon Generic Co Ltd
Yoshindo
NABIQASIM INDUSTRIES
Shin Poong Pharmaceutical
Ohara Inc
Kyorin Holding
KYOUSOUMIRAI PHARM
Teva
Alfresa Pharma
Lupin Laboratories
Astellas Pharma
Sawai Pharmaceutical
Viatris
Kaken Pharmaceutical
Segment by Type
Tablet
Sustained Release Tablets
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Beraprost Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Beraprost Sodium Market Overview
1.1 Product Overview and Scope of Beraprost Sodium
1.2 Beraprost Sodium Segment by Type
1.2.1 Global Beraprost Sodium Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Sustained Release Tablets
1.3 Beraprost Sodium Segment by Application
1.3.1 Global Beraprost Sodium Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Beraprost Sodium Market Size Estimates and Forecasts
1.4.1 Global Beraprost Sodium Revenue 2019-2030
1.4.2 Global Beraprost Sodium Sales 2019-2030
1.4.3 Global Beraprost Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Beraprost Sodium Market Competition by Manufacturers
2.1 Global Beraprost Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Beraprost Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Beraprost Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Beraprost Sodium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Beraprost Sodium, Product Type & Application
2.7 Beraprost Sodium Market Competitive Situation and Trends
2.7.1 Beraprost Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Beraprost Sodium Players Market Share by Revenue
2.7.3 Global Beraprost Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Beraprost Sodium Retrospective Market Scenario by Region
3.1 Global Beraprost Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Beraprost Sodium Global Beraprost Sodium Sales by Region: 2019-2030
3.2.1 Global Beraprost Sodium Sales by Region: 2019-2024
3.2.2 Global Beraprost Sodium Sales by Region: 2025-2030
3.3 Global Beraprost Sodium Global Beraprost Sodium Revenue by Region: 2019-2030
3.3.1 Global Beraprost Sodium Revenue by Region: 2019-2024
3.3.2 Global Beraprost Sodium Revenue by Region: 2025-2030
3.4 North America Beraprost Sodium Market Facts & Figures by Country
3.4.1 North America Beraprost Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Beraprost Sodium Sales by Country (2019-2030)
3.4.3 North America Beraprost Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Beraprost Sodium Market Facts & Figures by Country
3.5.1 Europe Beraprost Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Beraprost Sodium Sales by Country (2019-2030)
3.5.3 Europe Beraprost Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Beraprost Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Beraprost Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Beraprost Sodium Sales by Country (2019-2030)
3.6.3 Asia Pacific Beraprost Sodium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Beraprost Sodium Market Facts & Figures by Country
3.7.1 Latin America Beraprost Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Beraprost Sodium Sales by Country (2019-2030)
3.7.3 Latin America Beraprost Sodium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Beraprost Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Beraprost Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Beraprost Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Beraprost Sodium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Beraprost Sodium Sales by Type (2019-2030)
4.1.1 Global Beraprost Sodium Sales by Type (2019-2024)
4.1.2 Global Beraprost Sodium Sales by Type (2025-2030)
4.1.3 Global Beraprost Sodium Sales Market Share by Type (2019-2030)
4.2 Global Beraprost Sodium Revenue by Type (2019-2030)
4.2.1 Global Beraprost Sodium Revenue by Type (2019-2024)
4.2.2 Global Beraprost Sodium Revenue by Type (2025-2030)
4.2.3 Global Beraprost Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Beraprost Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Beraprost Sodium Sales by Application (2019-2030)
5.1.1 Global Beraprost Sodium Sales by Application (2019-2024)
5.1.2 Global Beraprost Sodium Sales by Application (2025-2030)
5.1.3 Global Beraprost Sodium Sales Market Share by Application (2019-2030)
5.2 Global Beraprost Sodium Revenue by Application (2019-2030)
5.2.1 Global Beraprost Sodium Revenue by Application (2019-2024)
5.2.2 Global Beraprost Sodium Revenue by Application (2025-2030)
5.2.3 Global Beraprost Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Beraprost Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Toray
6.1.1 Toray Corporation Information
6.1.2 Toray Description and Business Overview
6.1.3 Toray Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Toray Beraprost Sodium Product Portfolio
6.1.5 Toray Recent Developments/Updates
6.2 Taide Pharma
6.2.1 Taide Pharma Corporation Information
6.2.2 Taide Pharma Description and Business Overview
6.2.3 Taide Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Taide Pharma Beraprost Sodium Product Portfolio
6.2.5 Taide Pharma Recent Developments/Updates
6.3 Nichiiko
6.3.1 Nichiiko Corporation Information
6.3.2 Nichiiko Description and Business Overview
6.3.3 Nichiiko Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nichiiko Beraprost Sodium Product Portfolio
6.3.5 Nichiiko Recent Developments/Updates
6.4 Daiichi Sankyo Co Ltd
6.4.1 Daiichi Sankyo Co Ltd Corporation Information
6.4.2 Daiichi Sankyo Co Ltd Description and Business Overview
6.4.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
6.4.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
6.5 Nihon Generic Co Ltd
6.5.1 Nihon Generic Co Ltd Corporation Information
6.5.2 Nihon Generic Co Ltd Description and Business Overview
6.5.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
6.5.5 Nihon Generic Co Ltd Recent Developments/Updates
6.6 Yoshindo
6.6.1 Yoshindo Corporation Information
6.6.2 Yoshindo Description and Business Overview
6.6.3 Yoshindo Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yoshindo Beraprost Sodium Product Portfolio
6.6.5 Yoshindo Recent Developments/Updates
6.7 NABIQASIM INDUSTRIES
6.6.1 NABIQASIM INDUSTRIES Corporation Information
6.6.2 NABIQASIM INDUSTRIES Description and Business Overview
6.6.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
6.7.5 NABIQASIM INDUSTRIES Recent Developments/Updates
6.8 Shin Poong Pharmaceutical
6.8.1 Shin Poong Pharmaceutical Corporation Information
6.8.2 Shin Poong Pharmaceutical Description and Business Overview
6.8.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
6.8.5 Shin Poong Pharmaceutical Recent Developments/Updates
6.9 Ohara Inc
6.9.1 Ohara Inc Corporation Information
6.9.2 Ohara Inc Description and Business Overview
6.9.3 Ohara Inc Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ohara Inc Beraprost Sodium Product Portfolio
6.9.5 Ohara Inc Recent Developments/Updates
6.10 Kyorin Holding
6.10.1 Kyorin Holding Corporation Information
6.10.2 Kyorin Holding Description and Business Overview
6.10.3 Kyorin Holding Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kyorin Holding Beraprost Sodium Product Portfolio
6.10.5 Kyorin Holding Recent Developments/Updates
6.11 KYOUSOUMIRAI PHARM
6.11.1 KYOUSOUMIRAI PHARM Corporation Information
6.11.2 KYOUSOUMIRAI PHARM Beraprost Sodium Description and Business Overview
6.11.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.11.4 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
6.11.5 KYOUSOUMIRAI PHARM Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Beraprost Sodium Description and Business Overview
6.12.3 Teva Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva Beraprost Sodium Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Alfresa Pharma
6.13.1 Alfresa Pharma Corporation Information
6.13.2 Alfresa Pharma Beraprost Sodium Description and Business Overview
6.13.3 Alfresa Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Alfresa Pharma Beraprost Sodium Product Portfolio
6.13.5 Alfresa Pharma Recent Developments/Updates
6.14 Lupin Laboratories
6.14.1 Lupin Laboratories Corporation Information
6.14.2 Lupin Laboratories Beraprost Sodium Description and Business Overview
6.14.3 Lupin Laboratories Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lupin Laboratories Beraprost Sodium Product Portfolio
6.14.5 Lupin Laboratories Recent Developments/Updates
6.15 Astellas Pharma
6.15.1 Astellas Pharma Corporation Information
6.15.2 Astellas Pharma Beraprost Sodium Description and Business Overview
6.15.3 Astellas Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Astellas Pharma Beraprost Sodium Product Portfolio
6.15.5 Astellas Pharma Recent Developments/Updates
6.16 Sawai Pharmaceutical
6.16.1 Sawai Pharmaceutical Corporation Information
6.16.2 Sawai Pharmaceutical Beraprost Sodium Description and Business Overview
6.16.3 Sawai Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sawai Pharmaceutical Beraprost Sodium Product Portfolio
6.16.5 Sawai Pharmaceutical Recent Developments/Updates
6.17 Viatris
6.17.1 Viatris Corporation Information
6.17.2 Viatris Beraprost Sodium Description and Business Overview
6.17.3 Viatris Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Viatris Beraprost Sodium Product Portfolio
6.17.5 Viatris Recent Developments/Updates
6.18 Kaken Pharmaceutical
6.18.1 Kaken Pharmaceutical Corporation Information
6.18.2 Kaken Pharmaceutical Beraprost Sodium Description and Business Overview
6.18.3 Kaken Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Kaken Pharmaceutical Beraprost Sodium Product Portfolio
6.18.5 Kaken Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Beraprost Sodium Industry Chain Analysis
7.2 Beraprost Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Beraprost Sodium Production Mode & Process
7.4 Beraprost Sodium Sales and Marketing
7.4.1 Beraprost Sodium Sales Channels
7.4.2 Beraprost Sodium Distributors
7.5 Beraprost Sodium Customers
8 Beraprost Sodium Market Dynamics
8.1 Beraprost Sodium Industry Trends
8.2 Beraprost Sodium Market Drivers
8.3 Beraprost Sodium Market Challenges
8.4 Beraprost Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
